News

Khiron Becomes First Colombian Medical Cannabis Company to Export Live Cannabis Clones to Europe

Yahoo Finance · Khiron Life Sciences Corp. · last updated
Khiron Life Sciences Corp. To date, Khiron medical cannabis products have shown strong evidence as alternative treatments for ailments such as chronic pain, anxiety, insomnia, depression, epilepsy, migraines, and Parkinsons Disease. About Khiron Life Sciences Corp.Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. The Company has filled medical cannabis prescriptions in Colombia, Peru and the United Kingdom, and is positioned to commence sales of medical cannabis in Germany and Brazil in early 2021. Cautionary NotesForward-Looking StatementsThis press release may contain certain “forward-looking information”” and “”forward-looking statements”” within the meaning of applicable securities legislation.”
View full article

here today, more tomorrow

We’ve launched briefing.center with a focus on the press and media.

And we’ve added Citizen Cartwright, a daily quick-read news summary by veteran Washington journalist Linda Cartwright. We’ve also created a new voting rights knowledge center for Citizen Cartwright subscribers. (You can sign up for a dedicated morning email at citizencartwright.com.)

You can sign up here for full access to press and media and Citizen Cartwright on briefing.center.

You can use briefing.center as the center of your information management, or just one of your tools. We’re happy to discuss your information needs.

Sign up